Brain Tumour Research

Please select here to E-mail us

Please select here to request our free of charge E-mail or Printed Version of our monthly Cancer Research Newsletter

Please select here if you would like to view how to participate in our studies.

A STUDY ON THE USE OF GC10-100 IN CANCER OF THE BRAIN.

Summary

Between the years 1991 to 2003, more than 300 advanced cancer patients, followed the GC10-100 protocols. From this twelve years experience, we have reached the following conclusions:

1.- The GC10-100 organic medicinal extract functions basically by amending the chemistry of cancer cells and restoring them to normal functionality. By inducing the activation of DNA repair mechanisms in cancer cells, it brings to a halt the cellular proliferative processes. Small tumours or recently metastasized focuses are usually suppressed within the first month of treatment. Large tumour masses, on the other hand, are gradually induced to differentiate into benign, non-proliferative groups of cells, over a period of time, and can take 3 to 12 months to complete.

2.-  The monitoring of the chemical changes undergone inside a tumor, like those induced by the GC10-100, can only be studied through specially designed PET scans (PET = Positron Emission Tomography). A PET scan will provide information about the chemical activity and internal changes occurring within the tumour. An MRI or CAT scan can only provide image information, like changes in the size and form of the tumour mass. But, because the GC10-100 therapy induces dramatic chemical changes in the tumour itself, an MRI or CAT scan will not be able to detect efficiently these basic changes. A PET scan, can show changes like those in FDG metabolism, which is indicative of cellular tumorigenic activity. (FDG = 18-fluoro-2-deoxyglucose)

3.-  95% of the patients who have followed the GC10-100 protocols, started when they were at  very advanced or terminal stages of their disease. The average prognosis for these patients, as given to them by their oncologists, had been between 8 and 16 weeks to live.

4.- Because of the change in the terminal prognosis to a no longer terminal, and the dramatic improvements observed in 90% of the patients who used GC10-100 for at least 30 days continuously,  we can conclude that these protocols are the most powerful treatment today to allow reversal of malignancy through natural means.

5. - 85% of patients that used the GC10-100 protocols with success, had already tried and failed with all other available treatments. These included chemotherapeutic agents, surgical procedures and radiotherapy treatments. GC10-100 was, in all these patients, the only agent to which they responded positively in the long term.

6.- Advanced brain tumour patients who succeeded with the use of GC10-100, are mostly patients who used the GC10-100 under a proper medical supervision. Apart from the problems originating at the site of the tumour, advanced cancer patients are usually suffering from a large number of disabilities and medical problems of all kinds. These problems might need to be taken care of periodically and sometimes on a daily basis. A patient, for example, might be doing quite well with  his cancer treatment, however, at the same time, might be affected by a lung or a gastrointestinal infection, internal bleeding, edemas, pulmonary disfunction, seizures and many other clinical conditions that may require immediate medical assistance, to avoid becoming life-threatening events.

7.- At its present stage of production development,  the GC10-100 is extracted and separated from 100% natural organic sources. The total GC10-100, that can be produced by us each year, is limited by the amount of plant materials we are able to grow within the framework of our organic farming projects. GC10-100 is presently provided for clinical studies and in response to compassionate appeals to help terminally ill cancer patient worldwide.

8.- Patients with Glioblastoma Multiforme stage IV, who have used the GC10-100 for a period of 3 to 12 months continuously, have shown that they can reverse there serious condition into a treatable one. Some tumours that were inoperable can then be subjected to surgery. Once the aggressiveness of the cancer is reduced to standard levels, a number of options and treatments reemerge

9.- GC10-100 are natural formulations with their main ingredients extracted from specific organic plant sources, then fractionated and separated into their main molecular components. The extracts, GC10 to GC100, are produced by merging various molecular separations into different formulations.

10.- The product is presently available in 91 different grades and formulations from GC10 to GC100. With all of these formulations, it is recommended to start the first day with 1 teaspoonful the second day 2 and to continue with daily increments until reaching between six and eight teaspoonfuls a day. This gradual increase is necessary to activate intestinal enzymatic absorption of the organic extract. It is recommended to administer the product, in several small doses, throughout the day. It can be taken by itself, mixed with water, with bread or together with a tepid meal.

We have presented in our home page a few video testimonials and results from the more than one hundred advanced brain tumor patients who have been treated with GC10-100.

Nutritional Medicine Research
26 Priestgate, Peterborough
PE1 1WG. United Kingdom

Telephone:
From the USA :
01144 7930 915 588 (8 am to 4 pm)
01144 7919 415 841 (24 hours)


From all other countries:
0044 7930 915 588
0044 7919 415 841 (24 hours)


From the UK:
07930 915 588
07919 415 841 (24 hours)


FAX
From the USA: 01144 7939 010 379
From all other countries: 0044 7939 010 379
From the UK: 07939 010 379

 

[Home] [Clinical Trial] [Case Reports] [Protocol] [Anti-Tumor] [Brain Cancer] [1 Glioblastoma] [2  Glioblastoma] [3 Glioblastoma] [4 Glioblastoma] [5 Glioblastoma] [Medulloblastoma] [Contact us] [Seminar]
[Liver Cancer] [Ovarian Cancer] [Neuroblastoma] [Lung Cancer]